Summary
The myelin oligodendrocyte glycoprotein (MOG) is a major target for autoantibody mediated demyelination in experimental autoimmune encephalomyelitis (EAE). In the current review we discuss the epitope specificity of this antibody response, in particular evidence suggesting that pathogenic anti-MOG antibodies are preferentially directed against conformationdependent epitopes present on the extracellular immunoglobulin domain of the protein. Surprisingly, recent data suggest that this autoimmune response is in part regulated by polymorphisms in the MOG gene itself, an observation that may have important implications for the genetic and immunological stratification of patients with multiple sclerosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J-M, et al. (1995) The N-terminal domain of the myelin oligodoendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17–27
Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76: 355–364
Brehm U, Piddlesden S.J., Gardinier M.V., Linington C (1999) Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J Neuroimmunol 97: 9–15
Brunner C, Lassmann H, Waehneldt T.V., Matthieu J-M, Linington C (1989) Differential ultrastructurallocalization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2’,3’-cyclic nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296–304
della Gaspera B, Pham-Dinh D, Roussel G, Nussbaum J.L., Dautigny A (1998) Membrane topology of the myelin/oligodendrocyte glycoprotein. Eur J Biochem 258: 478–484
Gardinier M.V., Amiguet P, Linington C, Matthieu J-M (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33: 177–187
Gasser D.L., Newlin C.M., Palm J, Gonatas N.K. (1973) Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181: 872–873
Genain C.P., Hauser S.L. (1997) Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75: 187–197
Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5: 170–175
Ichikawa M, Johns T.G., Adelmann M, Bernard C.C. (1996) Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int Immunol 8: 1667–1674
Ichikawa M, Johns T.G., Liu J, Bernard C.C. (1996) Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157: 919–926
Ichikawa M, Koh C.S., Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard C.C., Komiyama A (1999) IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol 191: 97–104
Johns T.G., Kerlero de Rosbo N, Menon K.K., Abo S, Gonzales M.F., Bernard C.C. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154: 5536–5541
Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A (1999) Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol 56: 311–315
Kerlero de Rosbo N, Milo R, Lees M.B., Burger D, Bernard C.C.A., Ben-Nun A (1993) Reactivity to myelin antigens in multiple sclerosis. J Clin Invest 92: 2602–2608
Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27: 3059–3069
Kroepfl J.F., Viise L.R., Charron A.J., Linington C, Gardinier M.V. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J Neurochem 67: 2219–2222
Lambracht D, Prokop C, Hedrich H.J., Fischer Lindahl K, Wonigeit K (1995) Mapping of H2-M homolog and MOG genes in the rat MHC. Immunogen 42: 418–421
Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576
Lebar R, Lubetzki C, Vincent C, Lombrail P, Poutry J-M (1986) The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes. Clin Exp Immunol 66: 432–443
Lindert R, Haase C.G., Brehm U, Linington C, Wekerle H, Hohlfeld R (1999) MUltiple sclerosis: T and B cell responses to the extracellular domain of the myelin glycoprotein. Brain 122: 2089–2099
Linington C, Lassmann H (1987) Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titer to myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17: 61–70
Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454
Linington C, Morgan B.P., Scolding N.J., Piddlesden S, Wilkins P, Compston D.A.S. (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112: 895–911
Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23:1364–1372
Pham-Dinh D, Mattei M.G., Nussbaum J.L., Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Lindahl K.F., Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990–7994
Pham-Dinh D, Jones E.P., Pitiot G, Daubas P, Blanquet F, Ressot C, et al. (1995) Physical mapping of human and mouse MOG gene at the distal end of the MHC class Ib region. Immunogenetics 42: 386–391
Piddlesden S.J., Lassmann H, Zimprich F, Morgan B.P., Linington C (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143: 555–564
Piddlesden S.J., Storch M.K., Hibbs M, Freeman A.M., Lassmann H, Morgan B.P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152: 5477–5484
Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T (1999) Myelin oligodendrocyte glycoprotein specific autoantibodies in multiple sclerosis. Brain 122: 2047–2056
Schluesener H.J., Sobel R.A., Linington C, Weiner H.L. (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139: 4016–4021
Storch M.K., Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H (1998a) Multiple sclerosis: in situ evidence for antibody - and complement-mediated demyelination. Ann Neurol 43: 465–471
Storch M.K., Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. (1998b) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8: 681–694
Sun J, Link H, Olsson H, Xiao B, Andersson G, Ekre H-P, et al. (1991a) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146: 1490–1495
Wallstrom K, Khademi M, Andersoon M, Weissert R, Linington C, Olsson T (1998) Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2 (15)+ positive multiple sclerosis. Eur J Immunol 28: 3329–3335
Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C (1994) Animal models. Ann Neurol 36: S47–S53
Weissert R, Wallstorm E, Storch M.K., Stefferl A, Lorentzen J, Lassmann H, et al. (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102: 1265–1273
Xiao B, Linington C, Link H (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31: 91–96
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Stefferl, A., Brehm, U., Linington, C. (2000). The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. In: Mizuno, Y., Calne, D.B., Horowski, R., Poewe, W., Riederer, P., Youdim, M.B.H. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6284-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6284-2_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7246-9
Online ISBN: 978-3-7091-6284-2
eBook Packages: Springer Book Archive